PRLog Free Press Release Distribution + Bookmark This Page
Home| Submit Free Press Release| News Archive| By Category| By Location| By Date| Newsletter| 40,000 RSS Feeds 03:31 AM [GMT -05:00]
 

Filter

Category

Country

State / Province
Select Country First

City / Town
Select State First

AnaSpec Introduces Anti-MMP-1 & Anti-MMP-13 (Hinge) Antibodies

Strategically raised against the hinge regions of MMP-1 and MMP-13, the epitopes do not overlap the catalytic domain and will not influence the activity of the MMP ferment in experiments.
Issued By: AnaSpec Inc.
Jul 17, 2007 12:57:23
Click to see PDF Version of this Press Release

 

FOR IMMEDIATE RELEASE

PRLog (Press Release) – July 13, 2007 – San Jose, CA
AnaSpec has introduced its newest antibody solutions – anti-MMP-1 (Hinge) and anti-MMP-13 (Hinge) antibodies. Strategically raised against the hinge regions of MMP-1 and MMP-13, the epitopes do not overlap the catalytic domain and will not influence the activity of the MMP ferment in experiments. In response to customers’ suggestions, AnaSpec’s anti-MMP antibodies are packaged in efficient 50 ul sizes.
Matrix metalloproteinases (MMPs) are a family of highly homologous protein-degrading zinc dependent enzymes endopeptidases. These enzymes are responsible for the breakdown of connective tissues and are important in many normal biological processes including embryonic development, angiogenesis, bone remodeling, menstrual cycle, and wound healing. They are also involved in pathological processes such as inflammation, cancer, multiple sclerosis, Alzheimer’s, malignant gliomas, lupus, arthritis, periodontis, emphysema, glomerulonephritis, atherosclerosis, tissue ulceration, and tissue destruction. Imbalanced secretion of certain MMPs or disturbances in the differential control of MMP by tissue inhibitor of MMPs (TIMPs) is implicated in the invasive potential of malignant tumors.
This family currently includes more than 25 members that can be divided into collagenases (MMP-1, -8, -13 and -18), gelatinases (MMP-2 and -9), stromelysins (MMP-3 –7, -10, -11and -13), matrilysins (MMP-7 and -26), elastins (MMP-12), and the membrane-type MMPs (MMP-14 to –17, -20, and -21), according to their structure and substrate specificity.
Anti-MMP-1 (Hinge), Collagenase-1
Rabbit polyclonal anti-MMP-1 (Hinge) antibody was raised against a synthetic collagenase-1 peptide derived from the hinge region of human MMP-1. This interstitial collagenase (MMP-1) dissolves extracellular matrix (ECM) and may initiate and promote angiogenesis. MMP-1 (collagenase 1) is involved in tumor development and metastasis, and rheumatoid arthritis. Anti-MMP-1 (Hinge) reacts with MMP-1 at the molecular weight of 52 kDa as an unglycosylated and 57 kDa as a glycosylated pro-form of MMP-1.
Anti-MMP-13 (Hinge), Collagenase-3
Rabbit anti-MMP-13 (Hinge) polyclonal antibody was raised against a synthetic collagenase-3 peptide derived from the hinge region of human MMP-13. MMP-13 (collagenase-3) is a member of the MMP family of extracellular proteases. Targets of MMP-13 include collagen, gelatin, aggracan, plasminogen and CXCL12. MMP-13 is secreted as a 60-kDa proenzyme (as measured by SDS-PAGE), and activated by cleavage to a mature 48-kDa MMP-13. Anti-MMP-13 reacts with MMP-13 at the molecular weight of approximately 60 kDa at pro-form and 48 kDa at active form on Western blot.
For more information, visit http://www.anaspec.com/products/promotions.asp?col=2&row=3
Company Info

AnaSpec, Inc. is a leading provider of integrated proteomics solutions to pharmaceutical, biotech, and academic research institutions throughout the world. With a vision for innovation through synergy, AnaSpec focuses on three core technologies: peptides, detection reagents (dyes, assay kits, & antibodies), and combinatorial chemistry. Established in 1993, AnaSpec's ISO9001:2000 certified headquarters and manufacturing facilities are located in San Jose, CA.
For more information, visit www.anaspec.com
References:
1.   Woessner, JF. Jr. and CJ. Taplin, J. Biol. Chem. 263, 16918 (1988).
2.   Woessner, JF..Jr. FASEB J. 5, 2145 (1991).
3.   Goldberg, GI. et al. Ann. NY. Acad. Sci. 580, 375 (1990).
4.   Stetler-Stevenson, WG. et al. Annu. Rev. Cell Biol. 9, 541 (1993).
5.   Gravallese, EM. et al. Arthritis Rheum. 34, 1076 (1991).
6.   Gabison, e. et al. Am. J. Pathology 166, 209 (2005).
7.   Freije, JM. et al. J. Biol. Chem. 269, 16766 (1994)

# # # + Share This Article

Email to a Friend   Email to Author       Previous News   Next News


Email:Click to contact author
Categories:Biotech

Disclaimer:   Issuers of the press releases are solely responsible for the content of their press releases. PRLog.Org can't be held liable for the contents of the press releases.   Report Abuse


Search Jobs / Post Jobs New

Most Viewed (Last 7 days)

Shopit Store Reaches Chris Brown Fans - 494 views

How Does GPS Technology Work - 446 views

Things You Should Know About GPS - 284 views

Looking for an exciting weekend getaway? Come for a Ghost Hunting Weekend Retreat in TEXAS! - 281 views

Stylish and Sexy Plus Size Clothing from Cherished-Woman.com Featured on Hit NBC Television Show - 278 views

Eco-Populace, LLC Makes Newspaper For the 2nd Time in 30 Days. - 262 views

Metanomics Hosts Christian Renaud of Cisco Live on SLCN.TV - 259 views

India's leading Free Online SMS service 160by2.com Launches New Features For Their Users - 238 views

2009 Audi Q5 Quote now available at the audiq5site.com - 236 views

October Road Fan's ask Ellen Degeneres for help to bring their show back to television! - 216 views



Previous News

Next News

Are you a Journalist?


For Businesses ...


Tutorial on Free Marketing




How to Write a Press Release| SiteMap| Contact PRLog| Privacy Policy| Terms of Use| Copyright Notice